Skip to main content
letter
. 2023 Mar 23;48(8):2345–2349. doi: 10.1007/s11064-023-03912-0

Table 1.

Summary of symptoms, mechanisms and treatment targets of acute and chronic phases of COVID-19

Acute phase (first 4 weeks from infection) Chronic phase (after 4 weeks)
Symptoms

• Nasopharyngeal (sore throat, runny nose)

• Respiratory (cough, dyspnea)

• Systemic (fever, headache, fatigue)

• Respiratory (persistent cough, dyspnea, hypoxia)

• Cardiovascular (palpitation, chest pain)

• Neurological (headache, dizziness, numbness)

• Neuropsychiatric (short-term memory loss, inability to concentrate, depression, anxiety)

• Systemic (fatigue, muscular weakness, insomnia)

Known mechanisms

• Viral attack

• Inflammatory response

• Cytokine storm

• Immune response

• Chronic inflammation

• Pulmonary fibrosis

• Coagulopathy

Treatment targets

• Anti-viral medications

• Immunomodulatory agents (cytokine inhibitors, immune globulin)

• Supportive management

• Rehabilitation

• Vaccination

• Anti-coagulation